Shuansuo Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shuansuo Yang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Hua Liu
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China
2 shared publications - Hui Chen
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China
2 shared publications - Jinjie Dai
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China
2 shared publications - Lei Tang
School of Medical Graduate, Shanghai Jiaotong University, Shanghai, 200025, China
2 shared publications - Qian Gan
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China
2 shared publications - Ruogu Li
Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, NO.241, Huaihai Xi Road, Xuhui District, Shanghai, 200030, China
2 shared publications
Latest Publications
- RetractionOpen Access
- 27 March 2015
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 10 (1) , 43
Retraction Note: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions
- 27 March 2015
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 10 (1) , 43
RetractionOpen AccessRetraction Note: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions
- RetractedOpen Access
- 28 February 2014
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 41
RETRACTED ARTICLE: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions
Background and purpose: Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary. Methods: Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-term”, “follow-up” and “outcome”. Quality assessment was carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect model and random-effect model. Heterogeneity was assessed using the I 2 test, Q test, L’abbe and Galbraith. Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research. Results: A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were found significantly reduced associated with CTO success. Conclusions: Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.
- 28 February 2014
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 41
RetractedOpen AccessRETRACTED ARTICLE: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions
Background and purpose: Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary. Methods: Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-term”, “follow-up” and “outcome”. Quality assessment was carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect model and random-effect model. Heterogeneity was assessed using the I 2 test, Q test, L’abbe and Galbraith. Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research. Results: A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were found significantly reduced associated with CTO success. Conclusions: Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.
- 1 January 2014
- Vol. 35 (1) , 80-6
The effects of subclinical hypothyroidism on serum lipid level and TLR4 expression of monocyte in peripheral blood of rats.
To observe effect of subclinical hypothyroidism (SCH) on serum lipid level and expression of toll-like receptor 4 (TLR4) in rats' peripheral blood mononuclear cells (PBMC). Fifty Wistar female rats were divided into three groups: normal control (NC group; n=10), sham group (n=10), and L-T-4 (L-thyroxine) group (n=30, with thyroidectomy, fed with rich-calcium water after operation. 5 weeks later, abdominal subcutaneous injection of L-T-4: 0.95 μg/100g/d). 8 weeks later, the rats were killed then the peripheral blood was collected to determine the levels of serum thyroid-stimulating hormone (TSH), total thyroid hormone (TT4), total cholesterol (TC) and low density lipoprotein cholesterin (LDL-C). Rats in L-T-4 group were divided into normal lipid (NL) group) and high lipid (HL) group) according to lipid value of NC group. Monocytes were separated from blood to determine TLR4 expression by flow cytometry. In NL and HL groups TSH were higher than in NC and Sham groups (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) were increased (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) of PBMC and TNF-α, IL-6, IL-1β expression in serum were all increased in SCH rats, which was not related to serum dyslipidemia.
- 1 January 2014
- Vol. 35 (1) , 80-6
The effects of subclinical hypothyroidism on serum lipid level and TLR4 expression of monocyte in peripheral blood of rats.
To observe effect of subclinical hypothyroidism (SCH) on serum lipid level and expression of toll-like receptor 4 (TLR4) in rats' peripheral blood mononuclear cells (PBMC). Fifty Wistar female rats were divided into three groups: normal control (NC group; n=10), sham group (n=10), and L-T-4 (L-thyroxine) group (n=30, with thyroidectomy, fed with rich-calcium water after operation. 5 weeks later, abdominal subcutaneous injection of L-T-4: 0.95 μg/100g/d). 8 weeks later, the rats were killed then the peripheral blood was collected to determine the levels of serum thyroid-stimulating hormone (TSH), total thyroid hormone (TT4), total cholesterol (TC) and low density lipoprotein cholesterin (LDL-C). Rats in L-T-4 group were divided into normal lipid (NL) group) and high lipid (HL) group) according to lipid value of NC group. Monocytes were separated from blood to determine TLR4 expression by flow cytometry. In NL and HL groups TSH were higher than in NC and Sham groups (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) were increased (p0.05). TLR4, TLR4 mRNA, NF-κB (p65) of PBMC and TNF-α, IL-6, IL-1β expression in serum were all increased in SCH rats, which was not related to serum dyslipidemia.